Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
36 studies found for:    "Ocular melanoma"
Show Display Options
Rank Status Study
1 Unknown  Study of Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Interventions: Drug: Gemcitabine;   Drug: Treosulfan
2 Recruiting STA-9090(Ganetespib) in Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Intervention: Drug: STA-9090
3 Recruiting Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Interventions: Drug: Sorafenib;   Device: Radioembolization with SIR-Spheres® (Yttrium Microspheres)
4 Recruiting Adoptive T Cell Therapy for Metastatic Ocular Melanoma
Conditions: Metastatic Ocular Melanoma;   Metastatic Uveal Melanoma
Interventions: Drug: Aldesleukin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Tumor Infiltrating Lymphocytes
5 Recruiting Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Conditions: Iris Melanoma;   Medium/Large Size Posterior Uveal Melanoma;   Ocular Melanoma With Extraocular Extension;   Recurrent Uveal Melanoma;   Small Size Posterior Uveal Melanoma;   Stage IIIA Uveal Melanoma;   Stage IIIB Uveal Melanoma;   Stage IIIC Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Drug: Cabozantinib S-malate;   Drug: Temozolomide;   Drug: Dacarbazine;   Other: Laboratory Biomarker Analysis
6 Withdrawn Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye
Condition: Ocular Melanoma
Interventions: Drug: Pegylated Interfon Alpha 2B;   Drug: Placebo
7 Unknown  Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
Conditions: Ocular Melanoma;   Choroidal Melanoma;   Uveal Melanoma
Intervention:
8 Recruiting Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Ocular Melanoma With Extraocular Extension;   Recurrent Uveal Melanoma
Interventions: Drug: Vorinostat;   Other: Laboratory Biomarker Analysis
9 Active, not recruiting Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Iris Melanoma;   Medium/Large Size Posterior Uveal Melanoma;   Ocular Melanoma With Extraocular Extension;   Recurrent Uveal Melanoma;   Small Size Posterior Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Drug: Selumetinib;   Drug: Temozolomide;   Drug: Dacarbazine;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
10 Unknown  Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Condition: Ocular Melanoma
Intervention:
11 Completed THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease
Condition: Ocular Melanoma
Intervention: Drug: Ipilimumab
12 Recruiting Definity for Ultrasound of Intraocular Tumors
Condition: Ocular Melanoma
Intervention: Device: Microbubble contrast agent
13 Unknown  Cytogenetic Study of Ocular Melanoma
Condition: Choroidal Melanoma
Intervention:
14 Completed
Has Results
Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma
Condition: Melanoma
Intervention: Drug: Revlimid
15 Completed A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma
Condition: Melanoma
Intervention: Procedure: Laparotomy
16 No longer available Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Conditions: Metastatic Liver Cancer;   Ocular Melanoma;   Cutaneous Melanoma
Interventions: Drug: Melphalan;   Device: Percutaneous Hepatic Perfusion
17 Recruiting CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301in Treating Patients With Stage IIB-IV Melanoma
Conditions: Carcinoma of Unknown Primary Origin;   Iris Melanoma;   Medium/Large Size Posterior Uveal Melanoma;   Mucosal Melanoma;   Ocular Melanoma With Extraocular Extension;   Small Size Posterior Uveal Melanoma;   Stage IIB Skin Melanoma;   Stage IIB Uveal Melanoma;   Stage IIC Skin Melanoma;   Stage IIIA Skin Melanoma;   Stage IIIA Uveal Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIB Uveal Melanoma;   Stage IIIC Skin Melanoma;   Stage IIIC Uveal Melanoma;   Stage IV Skin Melanoma;   Stage IV Uveal Melanoma
Interventions: Biological: recombinant flt3 ligand;   Biological: DEC-205/NY-ESO-1 Fusion Protein CDX-1401;   Biological: Neoantigen-based Melanoma-Poly-ICLC Vaccine;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
18 Terminated Imatinib in Adult Patients With Metastatic Ocular Melanoma
Condition: Melanoma
Intervention: Drug: Imatinib
19 Unknown  Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Condition: Intraocular Melanoma
Interventions: Drug: cisplatin;   Drug: sunitinib malate;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy
20 Completed Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
Conditions: Stage IV Melanoma;   Recurrent Melanoma
Intervention: Biological: recombinant interferon beta

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Indicates status has not been verified in more than two years